Pectin from passiflora edulis shows anti-inflammatory action as well as hypoglycemic and hypotriglyceridemic properties in diabetic Rats

Journal of Medicinal Food

Volumn 14, Issue 10, 2011, Pages 1118-1126

  Silva, Draulio C ^a   Freitas, Ana L P ^a   Pessoa, Carla D S ^a   Paula, Regina C M ^a   Mesquita, Jacilane X ^a   Leal, Luzia K A M ^a   Brito, Gerly A C ^a   Gonçalves, Danilo O ^a   Viana, Glauce S B ^a,b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b Faculty of Medicine of Juazeiro Do Norte   (Brazil)

Author keywords

antidiabetic and anti inflammatory effects; cytokines; Passiflora edulis; pectin

Indexed keywords

CARRAGEENAN; EOSIN; GLIBENCLAMIDE; GLUCOSE; HEMATOXYLIN; INDUCIBLE NITRIC OXIDE SYNTHASE; METFORMIN; MYELOPEROXIDASE; PECTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISSECTION; DRUG EFFECT; ENZYME RELEASE; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; HYPOLIPEMIA; HYPOTRIGLYCERIDEMIA; IMMUNOHISTOCHEMISTRY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PASSION FRUIT; PAW EDEMA; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CARRAGEENAN; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; EDEMA; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE II; PASSIFLORA; PECTINS; PEROXIDASE; PLANT EXTRACTS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

PASSIFLORA EDULIS; RATTUS; RATTUS NORVEGICUS;

EID: 80054054838     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2010.0220     Document Type: Article

References (43)

1. Petry RD, Reginatto F, de-Paris, F, et al.: Comparative pharmacological study of hydroethanol extracts of Passiflora alata and Passiflora edulis leaves. Phytother Res 2001;15:162-167.
2. Agra MF, Silva KN, Basílio IJD, França PF, Barbosa-Filho JM: Survey of medicinal plants used in the region northeast of Brazil. Rev Bras Farmacogn 2008;18:472-508.
3. Boyle JP, HoneycuttAA, NarayanKM, et al.: Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001;124:1936-1940. (Pubitemid 33716504)
4. Morrish NJ, Wang SL, Stevens LK, Fuller JK, Keen H: Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia 2001;44:14-21.
5. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053. (Pubitemid 38579764)
6. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998;352:837-853.
7. Kalofoutis C, Piperi C, Kalofoutis A, et al.: Type II diabetes mellitus and cardiovascular risk factors: current therapeutic approaches. Exp Clin Cardiol 2007;12:17-28. (Pubitemid 46566811)
8. Mcfarlane SI, Banerji M, Sowers JR: Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001;86:713-718. (Pubitemid 32207485)
9. Golden SH, Folsom AR, Coresh J, et al.: Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the Atherosclerosis Risk in Communities Study. Diabetes 2002;51:3069-3076.
10. Reusch J: Diabetes, microvascular complications, and cardiovascular complications: What is it about glucose? J Clin Invest 2003;112:986-988. (Pubitemid 38056313)
11. Sowers JR, Epstein M, Frohlich ED: Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001;37:1053-1059. (Pubitemid 32304003)
12. Rask-Madsen C, King GI: Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 2007;3:46-56. (Pubitemid 46006612)
13. Duncan BB, Schmidt MI, Pankow JS, et al.: Low-grade systemic inflammation and the development of type 2 diabetes. Diabetes 2003;52:1799-1805.
14. Janebro DI, Queiroz MSR, Ramos AT, et al.: Efeito da farinha da casca do maracujá-amarelo (Passiflora edulis v. flavicarpa Deg.) nos níveis glicêmicos e lipídicos de pacientes diabéticos tipo 2. Braz J Pharmacogn 2008;18:724-732.
15. Ramos AT, Cunha MA, Sabaa-Srur AU, et al.: Uso de Passiflora edulis v. flavicarpa na redução do cholesterol. Braz J Pharmacogn 2007;17:592-597.
16. Stevenson TT, Furneaux RH: Chemical methods for the analysis of sulphated galactans from red algae. Carbohydr Res 1991;210: 277-298.
17. Lucisano YM, Mantovani B: Lysosomal enzyme release from polymorphonuclear leukocytes induced by immune complexes of IgM and of IgG. J Immunol 1984;132:2015-2020. (Pubitemid 14166676)
18. Yapo BM, Koffi KL: Yellow passion fruit rind: a potential source of low-methoxyl pectin. J Agric Food Chem 2006;54: 2738-2744.
19. Yapo BM: Biochemical characteristics and gelling capacity of pectin from yellow passion fruit rind as affected by acid extractant nature. J Agric Food Chem 2009;57:1572-1578.
20. Salman H, Bergman M, Djaldetti M, Orlin J, Bessler H: Citrus pectin affects cytokine production by human peripheral blood mononuclear cells. Biomed Pharmacother 2008;62:579-582.
21. Derivi SCN, Mendez MHM, Francisconi AD, et al.: Efeito hipoglicêmico de rações à base de berinjela (Solanum melongena, L.) em ratos. Ciênc Tecnol Aliment 2002;22:164-169.
22. Sandhu KS, El Samahi MM, Mena I, Dooley CP, Valenzuela JE: Effect of pectin on gastric emptying and gastro-duodenal motility in normal subjects. Gastroenterology 1987;92:486-492. (Pubitemid 17231732)
23. Jenkins AL, Jenkins DJ, Wolever TM, et al.: Postprandial glucose reductions with viscous fiber blind enriched biscuits in healthy subjects and patients with diabetes mellitus: acute randomized controlled clinical trial. Croat Med J 2008;49:772-782.
24. Uusitupa M, Tuomilehto J, Karttunen P,Wolf E: Long term effects of guar gum on metabolic control, serum cholesterol and blood pressure levels in type 2 (non-insulin-dependent) diabetic patients with high blood pressure. Ann Clin Res 1984;16:126-131. (Pubitemid 15111088)
25. Torsdottir I, Alpsten M, Holm G, Sandberg A-S, Töli J: A small dose of soluble alginate-fiber affects postprandial glycemia and gastric emptying in humans with diabetes. J Nutr 1991;121:795-799.
26. Wilson PWF, Agostino RBD, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-3072. (Pubitemid 43113437)
27. Steemburgo T, Dall'Alba V, Almeida JC, et al.: Intake of soluble fibers has a protective role for the presence of metabolic syndrome in patients with type 2 diabetes. Eur J Clin Nutr 2009;63: 127-133.
28. Theuwissen E, Mensink RP: Water-soluble dietary fibers and cardiovascular disease. Physiol Behav 2008;94:285-292. (Pubitemid 351615430)
29. Cannon CP: Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications. Am J Cardiol 2008;102:5-9.
30. Goldfine AB: Modulating LDL cholesterol and glucose in patients with type 2 mellitus: targeting the bile acid pathway. Curr Opin Cardiol 2008;23:502-511.
31. Queiroz RF, Maximiano FP, Nunes ES, et al.: Avaliação do perfil lipídico, glicêmico, conteúdo de glicogênio hepático e cardíaco em ratos diabéticos suplementados com farinha de casca de Maracujá (Passiflora edulis). Rev Bras Nutr Clin 2008;23:173-177.
32. Stone NJ: Non-pharmacological management of mixed dyslipidemia associated with diabetes mellitus and the metabolic syndrome: a review of the evidence. Am J Cardiol 2008;102:14-18.
33. Aleixandre A, Miguel M: Dietary fiber in the prevention and treatment of metabolic syndrome: a review. Crit Rev Food Sci Nutr 2008;48:905-912.
34. Di Bonito P, Sanguigno E,Di Fraia T, et al.: Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis. Metabolism 2009;58:368-372.
35. Oberlinner C, Zober A, Nawroth PP, Humpert PM, Morcos M. Alanine-aminotransferase levels predict impaired glucose tolerance in a worksite population. Acta Diabetol 2010;47: 161-165.
36. Feskens EJM, Loeber JG, Kromhout D: Diet and physical activity as determinants of hyperinsulinemia: The Zutphen Elderly Study. Am J Epidemiol 1994;140:350-360. (Pubitemid 24257931)
37. Marshall JA, Bessesen DH, Hamman RF: High saturated fat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population. The San Luis Valley Diabetes Study. Diabetologia 1997;40:430-438. (Pubitemid 27132613)
38. Salmeron J, Ascherio A, Rimm EB, et al.: Dietary fiber, glycemic load and risk of NIDDM in men. Diabetes Care 1997;20: 545-550. (Pubitemid 27143413)
39. Meyer KA, Kushi LH, Jacobs DR Jr, et al.: Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 2000;71:921-930. (Pubitemid 30176574)
40. Wisse BE: The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004;15:2792-2800. (Pubitemid 41103388)
41. Heilbronn LK, Campbell LV: Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Dis 2008;14:1225-1230. (Pubitemid 351997835)
42. Shah A, Methta N, Reilly MP: Adipose inflammation, insulin resistance, and cardiovascular disease. J Parenter Enteral Nutr 2008;32:638-644.
43. Popov SV, Popova GY, Paderin NM, et al.: Preventive anti-inflammatory effect of potamogetonan, a pectin from the common pondweed Potamogeton natans L. Phytother Res 2007;21:609-614. (Pubitemid 47066772)